Collectively, these results demonstrate that in diet-induced NASH mice, pharmacological activation of FXR by tropifexor reduced fibrosis, apoptosis, and inflammation, which was dependent, at least in part, on the induction of Fincor. Here, NR1H4 is linked to metabolic dysfunction-associated steatohepatitis.